In recent decades, based on the rapid development of high throughput technology, numerous biomarkers have been identified and applied to targeted treatment [9, 10], such as HER2 (human epidermal growth factor receptor 2) in breast cancer and EGFR (epidermal growth factor receptor) in lung cancer [11]. This evidence concerns the gene EGFR and breast carcinoma.